Survivin: A promising biomarker for detection and prognosis of bladder cancer

Vitaly Margulis, Yair Lotan, Shahrokh F. Shariat

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Survivin is a 16.5 kDa member of the inhibitor of apoptosis protein family that is overexpressed in many malignancies but rarely detected in normal differentiated adult tissues. Functionally, Survivin inhibits apoptosis, promotes cell proliferation, and induces/enhances angiogenesis. In transitional cell carcinoma of the urinary bladder, Survivin has been shown to be a promising biomarker for cancer diagnosis, prognosis and prediction of response to intravesical or systemic therapies. Moreover, in pre-clinical bladder tumor models, inhibition of Survivin expression and/or function has been shown to impede tumor cell proliferation, and markedly induce spontaneous or chemotherapy induced apoptosis. These preliminary findings should now be confirmed in large prospective trials. Furthermore, simplified, quantitative and reproducible assays need to be developed and validated for the detection of Survivin and its different isoforms.

Original languageEnglish (US)
Pages (from-to)59-65
Number of pages7
JournalWorld Journal of Urology
Volume26
Issue number1
DOIs
StatePublished - Feb 2008

Fingerprint

Urinary Bladder Neoplasms
Biomarkers
Cell Proliferation
Apoptosis
Inhibitor of Apoptosis Proteins
Transitional Cell Carcinoma
Tumor Biomarkers
Neoplasms
Protein Isoforms
Urinary Bladder
Drug Therapy
Therapeutics

Keywords

  • Bladder cancer
  • Detection
  • Prognosis
  • Survivin
  • Target
  • Urine

ASJC Scopus subject areas

  • Urology

Cite this

Survivin : A promising biomarker for detection and prognosis of bladder cancer. / Margulis, Vitaly; Lotan, Yair; Shariat, Shahrokh F.

In: World Journal of Urology, Vol. 26, No. 1, 02.2008, p. 59-65.

Research output: Contribution to journalArticle

@article{eb11655401f84bfbaae485e7487bbf3d,
title = "Survivin: A promising biomarker for detection and prognosis of bladder cancer",
abstract = "Survivin is a 16.5 kDa member of the inhibitor of apoptosis protein family that is overexpressed in many malignancies but rarely detected in normal differentiated adult tissues. Functionally, Survivin inhibits apoptosis, promotes cell proliferation, and induces/enhances angiogenesis. In transitional cell carcinoma of the urinary bladder, Survivin has been shown to be a promising biomarker for cancer diagnosis, prognosis and prediction of response to intravesical or systemic therapies. Moreover, in pre-clinical bladder tumor models, inhibition of Survivin expression and/or function has been shown to impede tumor cell proliferation, and markedly induce spontaneous or chemotherapy induced apoptosis. These preliminary findings should now be confirmed in large prospective trials. Furthermore, simplified, quantitative and reproducible assays need to be developed and validated for the detection of Survivin and its different isoforms.",
keywords = "Bladder cancer, Detection, Prognosis, Survivin, Target, Urine",
author = "Vitaly Margulis and Yair Lotan and Shariat, {Shahrokh F.}",
year = "2008",
month = "2",
doi = "10.1007/s00345-007-0219-y",
language = "English (US)",
volume = "26",
pages = "59--65",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Survivin

T2 - A promising biomarker for detection and prognosis of bladder cancer

AU - Margulis, Vitaly

AU - Lotan, Yair

AU - Shariat, Shahrokh F.

PY - 2008/2

Y1 - 2008/2

N2 - Survivin is a 16.5 kDa member of the inhibitor of apoptosis protein family that is overexpressed in many malignancies but rarely detected in normal differentiated adult tissues. Functionally, Survivin inhibits apoptosis, promotes cell proliferation, and induces/enhances angiogenesis. In transitional cell carcinoma of the urinary bladder, Survivin has been shown to be a promising biomarker for cancer diagnosis, prognosis and prediction of response to intravesical or systemic therapies. Moreover, in pre-clinical bladder tumor models, inhibition of Survivin expression and/or function has been shown to impede tumor cell proliferation, and markedly induce spontaneous or chemotherapy induced apoptosis. These preliminary findings should now be confirmed in large prospective trials. Furthermore, simplified, quantitative and reproducible assays need to be developed and validated for the detection of Survivin and its different isoforms.

AB - Survivin is a 16.5 kDa member of the inhibitor of apoptosis protein family that is overexpressed in many malignancies but rarely detected in normal differentiated adult tissues. Functionally, Survivin inhibits apoptosis, promotes cell proliferation, and induces/enhances angiogenesis. In transitional cell carcinoma of the urinary bladder, Survivin has been shown to be a promising biomarker for cancer diagnosis, prognosis and prediction of response to intravesical or systemic therapies. Moreover, in pre-clinical bladder tumor models, inhibition of Survivin expression and/or function has been shown to impede tumor cell proliferation, and markedly induce spontaneous or chemotherapy induced apoptosis. These preliminary findings should now be confirmed in large prospective trials. Furthermore, simplified, quantitative and reproducible assays need to be developed and validated for the detection of Survivin and its different isoforms.

KW - Bladder cancer

KW - Detection

KW - Prognosis

KW - Survivin

KW - Target

KW - Urine

UR - http://www.scopus.com/inward/record.url?scp=39349098773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39349098773&partnerID=8YFLogxK

U2 - 10.1007/s00345-007-0219-y

DO - 10.1007/s00345-007-0219-y

M3 - Article

C2 - 17962949

AN - SCOPUS:39349098773

VL - 26

SP - 59

EP - 65

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 1

ER -